Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

CASI Pharmaceuticals Inc. buy melinda

CASI Pharmaceuticals Inc.

Start price

€32.92

/ 50%

Target price

02.04.18

Performance (%)

End price

€41.31

Summary

This prediction ended on with a price of €41.31. The prediction had a final performance of . melinda has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
CASI Pharmaceuticals Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by melinda for this prediction

In the thread Casi Pharmaceuticals Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 4.059

Change

Ends at

Biotechnologie und Medizintechnik SecteurRecherche Agenda 17/05 Ergebnisse Veröffentlichung

CASI Pharma um 17% , um die Darstellung von Daten auf ENMD-2076 erhöhte

CASI Pharmaceuticals ( CASI + 17,3%) um über 50% erhöht nach ihrer Ankündigung einer Präsentation von Phase - 2 - Daten auf ENMD-2076 in triple negativem Brustkrebs im San Antonio Breast Cancer Symposium 7 Dezember.
ENMD-2076 ist ein Multi - Kinase - Inhibitor kleines Molekül mit mehreren Wirkmechanismen.

0

Prediction Buy

Perf. (%)

Target price 4.059

Change

Ends at

(Vom Mitglied beendet)

0

Stopped prediction by melinda for CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€14.20

04.11.21

50%

CASI Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€17.60

08.09.20

50%

CASI Pharmaceuticals Inc.

Start price

Target price

Perf. (%)

€31.57

08.11.18

50%